Nisha Rao1,2, Henry A Spiller2,3, Nichole L Hodges1,2, Thiphalak Chounthirath1, Marcel J Casavant1,2,3, Amrit K Kamboj1,4, Gary A Smith5,6,7. 1. Center for Injury Research and Policy of the Research Institute at Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. 2. The Ohio State University College of Medicine, Columbus, OH, USA. 3. Central Ohio Poison Center, Columbus, OH, USA. 4. Mayo Clinic, Division of General Internal Medicine, Rochester, MN, USA. 5. Center for Injury Research and Policy of the Research Institute at Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA. gary.smith@nationwidechildrens.org. 6. The Ohio State University College of Medicine, Columbus, OH, USA. gary.smith@nationwidechildrens.org. 7. Child Injury Prevention Alliance, Columbus, OH, USA. gary.smith@nationwidechildrens.org.
Abstract
INTRODUCTION: The objective of this study was to investigate the epidemiology of dietary supplement exposures in the USA. METHODS: A retrospective analysis was conducted of out-of-hospital dietary supplement exposures reported to the National Poison Data System from 2000 through 2012. RESULTS: There were 274,998 dietary supplement exposures from 2000 through 2012. The annual rate of dietary supplement exposures per 100,000 population increased by 46.1% during 2000-2002, decreased 8.8% during 2002-2005, and then increased again by 49.3% from 2005 to 2012. These trends were influenced by the decrease in ma huang exposures starting in 2002. Miscellaneous dietary supplements accounted for 43.9% of all exposures, followed by botanicals (31.9%), hormonal products (15.1%), and other supplements (5.1%). The majority of dietary supplement exposures (70.0%) occurred among children younger than 6 years old and were acute (94.0%) and unintentional (82.9%). Serious medical outcomes accounted for 4.5% of exposures and most (95.0%) occurred among individuals 6 years and older. Ma huang products, yohimbe, and energy products were the categories associated with the greatest toxicity. CONCLUSIONS: There was an overall increase in the rate of dietary supplement exposures from 2000 through 2012. Although the majority of these exposures did not require treatment at a health care facility or result in serious medical outcomes, exposures to yohimbe and energy products were associated with considerable toxicity. Our results demonstrate the success of the FDA ban on ma huang products and the need for FDA regulation of yohimbe and energy products in the USA.
INTRODUCTION: The objective of this study was to investigate the epidemiology of dietary supplement exposures in the USA. METHODS: A retrospective analysis was conducted of out-of-hospital dietary supplement exposures reported to the National Poison Data System from 2000 through 2012. RESULTS: There were 274,998 dietary supplement exposures from 2000 through 2012. The annual rate of dietary supplement exposures per 100,000 population increased by 46.1% during 2000-2002, decreased 8.8% during 2002-2005, and then increased again by 49.3% from 2005 to 2012. These trends were influenced by the decrease in ma huang exposures starting in 2002. Miscellaneous dietary supplements accounted for 43.9% of all exposures, followed by botanicals (31.9%), hormonal products (15.1%), and other supplements (5.1%). The majority of dietary supplement exposures (70.0%) occurred among children younger than 6 years old and were acute (94.0%) and unintentional (82.9%). Serious medical outcomes accounted for 4.5% of exposures and most (95.0%) occurred among individuals 6 years and older. Ma huang products, yohimbe, and energy products were the categories associated with the greatest toxicity. CONCLUSIONS: There was an overall increase in the rate of dietary supplement exposures from 2000 through 2012. Although the majority of these exposures did not require treatment at a health care facility or result in serious medical outcomes, exposures to yohimbe and energy products were associated with considerable toxicity. Our results demonstrate the success of the FDA ban on ma huang products and the need for FDA regulation of yohimbe and energy products in the USA.
Entities:
Keywords:
Dietary supplement; Energy products; Ma huang; Poison control center; Yohimbe
Authors: Mary E Palmer; Christine Haller; Patrick E McKinney; Wendy Klein-Schwartz; Anne Tschirgi; Susan C Smolinske; Alan Woolf; Bruce M Sprague; Richard Ko; Gary Everson; Lewis S Nelson; Teresa Dodd-Butera; W Dana Bartlett; Brian R Landzberg Journal: Lancet Date: 2003-01-11 Impact factor: 79.321
Authors: Sara M Seifert; Steven A Seifert; Judy L Schaechter; Alvin C Bronstein; Blaine E Benson; Eugene R Hershorin; Kristopher L Arheart; Vivian I Franco; Steven E Lipshultz Journal: Clin Toxicol (Phila) Date: 2013-08 Impact factor: 4.467
Authors: Nisha Rao; Henry A Spiller; Nichole L Hodges; Thiphalak Chounthirath; Marcel J Casavant; Amrit K Kamboj; Gary A Smith Journal: J Med Toxicol Date: 2017-11-28